# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Poster Includes Preclinical Data on Novel Direct Pan-RAS InhibitorsCARLSBAD, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Qualige...
https://www.nature.com/articles/s41598-024-54080-2
Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted wea...
Initiated dosing of three patients in first cohort of Phase 1 clinical trial of QN-302 for treatment of advanced or metastatic ...
Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and...